A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.

Dr Benjamin Levy explores research linking alcohol to GI cancers, and how physicians and public health experts can help individuals dramatically reduce their alcohol consumption.

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Adjunctive D-serine fails to outperform placebo in major depressive disorder but offers benefit in severe cases, especially ...

Obefazimod shows efficacy and favourable safety in patients with moderate to severely active ulcerative colitis in a 96-week ...

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

A new analysis of Medicare reimbursement for GI procedures shows that physicians lost ground while hospitals and ambulatory ...

Take a fascinating look back at the events that shaped medical news and how Medscape has evolved with the times.

Take a fascinating look back at the science and technology advances that shaped medicine’s past and will define its future.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...